Trial Profile
A Phase 1 dose-ranging study of EP-101 STEMVAC in HER2- advanced stage breast cancer patients
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 May 2017
Price :
$35
*
At a glance
- Drugs EP 101-EpiThany (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 18 May 2017 New trial record